Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma

Bone Marrow Transplant. 2023 Nov;58(11):1275-1278. doi: 10.1038/s41409-023-02078-1. Epub 2023 Aug 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dysbiosis
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Melphalan / adverse effects
  • Multiple Myeloma* / therapy
  • Transplantation Conditioning / adverse effects
  • Transplantation, Autologous

Substances

  • Melphalan